Oasis Capital Dialogue with Researcher Zhou Hao: Full of Curiosity
***Oasis: Could you give us a brief introduction to your research focus?***
Articles
Inside Dalton Venture's Family of Companies | Boosting Long-Term Survival Rates with a Single Injection: How This Innovative Drug Developer Is Taking on Leukemia
CAR-T cell therapy is seen as a new hope in humanity's fight against cancer.
Linear Capital portfolio company **Baiyi Huixin** launches **DetecMicro**, a vascular interventional surgery planning software
On June 16, 2023, **Baiyi Huixin held its product launch event in Beijing under the theme "Seeing the Small to Know the Great, Moving to See the Future." At the event, the company unveiled its DetecMicro vascular interventional surgical planning software.**
Yunqi Capital's Ma Chengyu Named to PEDaily's TOP100 Investors List
Focus on the long term and keep digging deeper.
BlueRun Ventures' "Explorer Day": We Talked to Hong Kong Entrepreneurs About a Thousand and One Futures for AI
Technology Innovation Opens a New Chapter for Hong Kong
Into the Dalton Venture Family | Leveraging Two Technology Platforms — Low-Temperature Plasma and Radiofrequency Ablation — Favamed Charts a Platform Strategy
As of today, Fangrun Medical and its subsidiaries have secured 19 NMPA registrations. Its products are now used in over 1,200 hospitals across China, with successful exports to Europe and Southeast Asia, serving more than 100,000 patients annually.
Linear Capital Portfolio Company DigiSight Ophthalmic Surgery Robot Completes Asia's First Clinical Application of Ophthalmic Robotics
Recently, portfolio company of Linear Capital **Hangzhou Disight Medical Biotechnology Co., Ltd.** successfully completed its first retinal sub-thrombolysis surgery for treating macular hemorrhage using its **"Disight MicroEdge"** ophthalmic surgical robot at Zhejiang Provincial People's Hospital. The procedure was safe and smooth, the patient recovered well, and has since been discharged in stable condition. This marks the first clinical application of an ophthalmic robot in Asia, representing a major technological advance for the entire field of ophthalmic microsurgery.
BlueRun Ventures' Jui Chan Named to PEDaily's 2023 TOP100 Investors
Support founders who refuse to be defined and dare to go first.
Linear Academy | What We Discussed at the "ToB Tech Enterprise Operations Management Salon"
Not long ago, Linear Capital and its portfolio company Guandata co-hosted a "ToB Tech Company Operations Management Salon" — a "homework submission" event that followed up on a Huawei BLM workshop Linear Academy had organized for portfolio companies two years prior. It was warmly received by founders across Linear's portfolio. At the event, Monica, formerly a business operations specialist at Sensors Data, drew on her practical experience since first encountering Huawei's BLM to discuss "enterprise operations management systems."
The Golden Age of Large Models and Generative AI: Every Application Will Be Refreshed and Rewritten | Ronghui Visits Microsoft
Generative AI is driving industry-wide transformation.